People living in prison must be included in country monitoring systems to accurately assess HCV elimination progress.

Autor: Tavoschi L; Department of Translational Medicine, University of Pisa, Pisa, Italy. Electronic address: lara.tavoschi@unipi.it., Cocco N; Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy., Alves da Costa F; Research Institute for Medicines (iMED), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal; Special Initiative on NCDs and Innovation, WHO Regional Office for Europe, Copenhagen, Denmark., Lloyd AR; Kirby Institute, University New South Wales, Sydney, NSW, Australia., Kinner SA; Justice Health Group, Faculty of Health Sciences, Curtin University, Perth, WA, Australia; School of Population Health, Curtin University, Perth, WA, Australia; Justice Health Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Jazyk: angličtina
Zdroj: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Jun; Vol. 9 (6), pp. 500-501.
DOI: 10.1016/S2468-1253(24)00075-X
Abstrakt: Competing Interests: LT has received funding and grants from Italian public institutions and the EU. LT and FAdC have received consulting fees from WHO. SAK serves on the Steering Group for the WHO Health in Prisons Programme. FAdC has received support for attending conferences from Springer journals. FAdC works as a public health consultant for the WHO Regional Office for Europe. The author alone is responsible for the views expressed in this publication and these do not necessarily represent the decisions or the stated policy of WHO. NC and ARL declare no competing interests.
Databáze: MEDLINE